A 61-year-old man presented to rheumatology clinic for evaluation of subacute ear swelling and pain. Physical examination demonstrated edematous, tender pinnae with sparing of the earlobes bilaterally (Fig. 1 Panel A). He had a C-reactive protein of 109.7 (<8.1 mg/L) and a proteinase 3 antibody of 74 AU/mL (26 AU/mL or greater defined as positive). An audiogram demonstrated sensorineural hearing loss. A diagnosis of relapsing polychondritis (RPC) secondary to granulomatosis with polyangiitis (GPA) was made. Treatment with prednisone was initiated and on follow-up 8 weeks later, he had improvement in auricular inflammation (Fig. 1 Panel B). Rituximab was initiated for induction therapy of GPA.
WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.